ストックスクリーナーアプリを入手
11.31
0.35%
0.04
アフターアワーズ：
11.30
-0.010
-0.09%
Xencor Inc (XNCR) 最新ニュース
Xencor, Inc. (XNCR) Competitors - Meyka
Xencor Inc. (XNCR) Holds Near Support as Biotech Sector Shows Mixed SignalsCrowd Entry Points - Newser
Xencor (XNCR) Q1 2026 Underperforms: Key Challenges AheadPro Level Trade Signals - Newser
Xencor’s SWOT analysis: biotech stock faces pipeline execution test - Investing.com
Xencor’s SWOT analysis: biotech stock faces pipeline execution test By Investing.com - Investing.com Canada
Xencor (XNCR) Q1 2026 Disappoints — EPS $-1.71 Below $-0.79 ViewsPopular Trader Picks - Newser
T-cell Engagers Market to Record US$ 58.04 billion by 2035., - openPR.com
Xencor Inc stock (US98401F1057): JPMorgan lifts target while investors eye Q1 2026 update - AD HOC NEWS
Xencor, Inc. $XNCR Shares Sold by UBS Group AG - MarketBeat
EcoR1 reports 2.9% Xencor stake (NASDAQ: XNCR) - Stock Titan
Xencor stock (US98401F1057): Biotech focus on immunotherapy and protein engineering - AD HOC NEWS
Xencor (XNCR) Declines -2.50% Amid Market Weakness 2026-05-14Undervalued Stocks - Newser
Xencor stock (US98401F1057): Biotech innovator in antibody therapies - AD HOC NEWS
Xencor Is Maintained at Neutral by JP Morgan - Moomoo
TD Cowen Maintains Xencor(XNCR.US) With Buy Rating - Moomoo
J.P. Morgan Maintains Xencor(XNCR.US) With Hold Rating, Raises Target Price to $14 - Moomoo
Xencor (NASDAQ:XNCR) Price Target Raised to $14.00 at JPMorgan Chase & Co. - MarketBeat
These Analysts Just Made A Huge Downgrade To Their Xencor, Inc. (NASDAQ:XNCR) EPS Forecasts - simplywall.st
XNCR (Xencor) crushes Q4 estimates with 85% earnings surprise, revenue rises 13.7%, shares jump 4.5%.Open Signal Network - Newser
Xencor (NASDAQ:XNCR) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
Xencor (XNCR) Receives a Buy from Wells Fargo - The Globe and Mail
These Analysts Think Xencor, Inc.'s (NASDAQ:XNCR) Sales Are Under Threat - Yahoo Finance
Xencor (NASDAQ:XNCR) Downgraded by Zacks Research to "Strong Sell" - MarketBeat
Xencor, Inc. (XNCR) Stock Analysis: Exploring A 132% Potential Upside In Biotech - DirectorsTalk Interviews
What Xencor (XNCR) is doing to earn customer loyalty (Falls Hard) 2026-05-08Small Cap Breakouts - Newser
MSN Money - MSN
Number of shareholders of Xencor, Inc. – MUN:XE9 - TradingView
Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Xencor (NASDAQ:XNCR) Releases Earnings Results, Misses Estimates By $1.06 EPS - MarketBeat
Earnings Flash (XNCR) Xencor, Inc. Reports Q1 Revenue $4.5M - marketscreener.com
Xencor: Q1 Earnings Snapshot - marketscreener.com
Xencor (NASDAQ: XNCR) posts deeper Q1 2026 loss amid royalty dispute and Zenas write-down - Stock Titan
Xencor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Xencor (NASDAQ: XNCR) Q1 loss widens as revenue and royalties fall - Stock Titan
Xencor Reports First Quarter 2026 Financial Results - Business Wire
Xencor trying to close in on key technical benchmark - MSN
Xencor Highlights XmAb942 Phase 1 Data, Previews TL1A/IL-23 Bispecific XmAb412 at DDW 2026 - MarketBeat
Buy Rating on Xencor as TL1A Franchise Data and Upcoming Phase IIb Catalyst Support Upside Potential - TipRanks
Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412Slideshow - Seeking Alpha
Behavioral Patterns of XNCR and Institutional Flows - Stock Traders Daily
Xencor Highlights TL1A Autoimmune Portfolio and IBD Strategy - TipRanks
Xencor presents Phase 1 XmAb942 final results; XmAb412 FIH study on track for 3Q26 - TradingView
Xencor (XNCR) expands TL1A franchise with XmAb942 data and XmAb412 moving to clinic - Stock Titan
Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW - Business Wire
Xencor (XNCR) Projected to Post Earnings on Wednesday - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Xencor (NASDAQ:XNCR) Stock Price Down 8%Should You Sell? - MarketBeat
Xencor Adopts Executive Severance Policy to Support Retention - The Globe and Mail
Xencor Gears Up For DDW 2026 Readouts, 2H26 Pipeline Catalysts - RTTNews
Xencor (NASDAQ:XNCR) Stock Passes Above 50 Day Moving AverageTime to Sell? - MarketBeat
Xencor (NASDAQ: XNCR) seeks approval for 4M new equity plan shares and auditor - Stock Titan
[ARS] Xencor Inc SEC Filing - Stock Titan
Executive severance plan at Xencor (NASDAQ: XNCR) adds change-in-control terms - Stock Titan
2.98%
1.33%
大文字化:
|
ボリューム (24 時間):